These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing. He X; Quan S; Xu M; Rodriguez S; Goh SL; Wei J; Fridman A; Koeplinger KA; Carroll SS; Grobler JA; Espeseth AS; Olsen DB; Hazuda DJ; Wang D Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33766889 [TBL] [Abstract][Full Text] [Related]
3. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 replicon for high-throughput antiviral screening. Zhang QY; Deng CL; Liu J; Li JQ; Zhang HQ; Li N; Zhang YN; Li XD; Zhang B; Xu Y; Ye HQ J Gen Virol; 2021 May; 102(5):. PubMed ID: 33956592 [TBL] [Abstract][Full Text] [Related]
5. A novel cell culture system modeling the SARS-CoV-2 life cycle. Ju X; Zhu Y; Wang Y; Li J; Zhang J; Gong M; Ren W; Li S; Zhong J; Zhang L; Zhang QC; Zhang R; Ding Q PLoS Pathog; 2021 Mar; 17(3):e1009439. PubMed ID: 33711082 [TBL] [Abstract][Full Text] [Related]
6. Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors. Luo Y; Yu F; Zhou M; Liu Y; Xia B; Zhang X; Liu J; Zhang J; Du Y; Li R; Wu L; Zhang X; Pan T; Guo D; Peng T; Zhang H mBio; 2021 Jan; 12(1):. PubMed ID: 33468688 [TBL] [Abstract][Full Text] [Related]
8. A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation. Chen Z; Cui Q; Ran Y; Achi JG; Chen Z; Rong L; Du R J Virol; 2024 Jul; 98(7):e0050424. PubMed ID: 38899934 [TBL] [Abstract][Full Text] [Related]
9. Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2. Xiao X; Wang C; Chang D; Wang Y; Dong X; Jiao T; Zhao Z; Ren L; Dela Cruz CS; Sharma L; Lei X; Wang J Front Immunol; 2020; 11():586572. PubMed ID: 33324406 [TBL] [Abstract][Full Text] [Related]
10. A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2. Das M; Kumar M; Jha A; Madhukiran DR; Bharti K; Mondal S; Mishra B Curr Drug Targets; 2021; 22(11):1232-1254. PubMed ID: 33371846 [TBL] [Abstract][Full Text] [Related]
11. Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro). Rothan HA; Teoh TC Mol Biotechnol; 2021 Mar; 63(3):240-248. PubMed ID: 33464543 [TBL] [Abstract][Full Text] [Related]
12. A high-throughput drug screening strategy against coronaviruses. Liu J; Li K; Cheng L; Shao J; Yang S; Zhang W; Zhou G; de Vries AAF; Yu Z Int J Infect Dis; 2021 Feb; 103():300-304. PubMed ID: 33333250 [TBL] [Abstract][Full Text] [Related]
13. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV. Milewska A; Chi Y; Szczepanski A; Barreto-Duran E; Dabrowska A; Botwina P; Obloza M; Liu K; Liu D; Guo X; Ge Y; Li J; Cui L; Ochman M; Urlik M; Rodziewicz-Motowidlo S; Zhu F; Szczubialka K; Nowakowska M; Pyrc K J Virol; 2021 Jan; 95(4):. PubMed ID: 33219167 [TBL] [Abstract][Full Text] [Related]
14. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies. Nguyen HT; Falzarano D; Gerdts V; Liu Q J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580 [TBL] [Abstract][Full Text] [Related]
15. High-Throughput SARS-CoV-2 Antiviral Testing Method Using the Celigo Image Cytometer. St Clair LA; Chan LL; Boretsky A; Lin B; Spedding M; Perera R J Fluoresc; 2024 Mar; 34(2):561-570. PubMed ID: 37310590 [TBL] [Abstract][Full Text] [Related]
16. A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry. Xu M; Pradhan M; Gorshkov K; Petersen JD; Shen M; Guo H; Zhu W; Klumpp-Thomas C; Michael S; Itkin M; Itkin Z; Straus MR; Zimmerberg J; Zheng W; Whittaker GR; Chen CZ SLAS Discov; 2022 Mar; 27(2):86-94. PubMed ID: 35086793 [TBL] [Abstract][Full Text] [Related]
17. An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo. Li Y; Tan X; Deng J; Liu X; Liu Q; Zhang Z; Huang X; Shen C; Xu K; Zhou L; Chen Y Virol Sin; 2024 Jun; 39(3):447-458. PubMed ID: 38548102 [TBL] [Abstract][Full Text] [Related]
18. Advanced microscopy technologies enable rapid response to SARS-CoV-2 pandemic. Cortese M; Laketa V Cell Microbiol; 2021 Jul; 23(7):e13319. PubMed ID: 33595881 [TBL] [Abstract][Full Text] [Related]
19. High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directions. Xu T; Zheng W; Huang R Drug Discov Today; 2021 Oct; 26(10):2439-2444. PubMed ID: 34048893 [TBL] [Abstract][Full Text] [Related]
20. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study]. Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]